Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor

Genes Chromosomes and Cancer

Volumn 50, Issue 6, 2011, Pages 379-388

  Toth, George ^a   Zraly, Claudia B ^a,b   Thomson, Tricia L ^a,c   Jones, Carolyn ^a,c   Lapetino, Shawn ^a,c   Muraskas, Jonathan ^a,c   Zhang, Jiwang ^a,b,c   Dingwall, Andrew K ^a,b,c  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 6; GLIAL FIBRILLARY ACIDIC PROTEIN; MYC PROTEIN;

ALLELE; ARTICLE; CASE REPORT; CHILDHOOD CANCER; CHROMOSOME 22Q; CLEFT LIP; CLEFT PALATE; COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL MALFORMATION; EAR MALFORMATION; EXON; GENE DELETION; GENE INACTIVATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HUMAN TISSUE; INFANT; MALE; PRIORITY JOURNAL; RHABDOID TUMOR; SMARCB1 GENE; SOMATIC CELL GENETICS; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ABNORMALITIES, MULTIPLE; ALLELES; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HUMANS; INFANT, NEWBORN; MALE; RECOMBINATION, GENETIC; RHABDOID TUMOR; TRANSCRIPTION FACTORS;

EID: 79954424274     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20862     Document Type: Article

References (55)

1. Abuazza G, Becker A, Williams SS, Chakravarty S, Truong HT, Lin F, Baum M. 2006. Claudins 6, 9, and 13 are developmentally expressed renal tight junction proteins. Am J Physiol Renal Physiol 291: F1132-F1141.
2. Aggarwal VS, Morrow BE. 2008. Genetic modifiers of the physical malformations in velo-cardio-facial syndrome/DiGeorge syndrome. Dev Disabil Res Rev 14: 19-25.
3. Albihn A, Johnsen JI, Henriksson MA. 2010. MYC in oncogenesis and as a target for cancer therapies. Adv Cancer Res 107: 163-224.
4. Baldwin EL, Lee JY, Blake DM, Bunke BP, Alexander CR, Kogan AL, Ledbetter DH, Martin CL. 2008. Enhanced detection of clinically relevant genomic imbalances using a targeted plus whole genome oligonucleotide microarray. Genet Med 10: 415-429.
5. Ben-Shachar S, Ou Z, Shaw CA, Belmont JW, Patel MS, Hummel M, Amato S, Tartaglia N, Berg J, Sutton VR, Lalani SR, Chinault AC, Cheung SW, Lupski JR, Patel A. 2008. 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome. Am J Hum Genet 82: 214-221.
6. Biegel JA. 2006. Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg Focus 20: E11.
7. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. 1999. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59: 74-79.
8. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. 2002. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8: 3461-3467.
9. Birks DK, Kleinschmidt-DeMasters BK, Donson AM, Barton VN, McNatt SA, Foreman NK, Handler MH. 2010. Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors. Brain Pathol 20: 140-150.
10. Boyd C, Smith MJ, Kluwe L, Balogh A, Maccollin M, Plotkin SR. 2008. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 74: 358-366.
11. Derbent M, Yilmaz Z, Baltaci V, Saygili A, Varan B, Tokel K. 2003. Chromosome 22q11.2 deletion and phenotypic features in 30 patients with conotruncal heart defects. Am J Med Genet A 116A: 129-135.
12. Edelmann L, Pandita RK, Morrow BE. 1999a. Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am J Hum Genet 64: 1076-1086.
13. Edelmann L, Spiteri E, McCain N, Goldberg R, Pandita RK, Duong S, Fox J, Blumenthal D, Lalani SR, Shaffer LG, Morrow BE. 1999b. A common breakpoint on 11q23 in carriers of the constitutional t(11;22) translocation. Am J Hum Genet 65: 1608-1616.
14. Eilers M, Eisenman RN. 2008. Myc's broad reach. Genes Dev 22: 2755-2766.
15. Fernandez L, Nevado J, Santos F, Heine-Suner D, Martinez-Glez V, Garcia-Minaur S, Palomo R, Delicado A, Pajares IL, Palomares M, Garcia-Guereta L, Valverde E, Hawkins F, Lapunzina P. 2009. A deletion and a duplication in distal 22q11.2 deletion syndrome region. Clinical implications and review. BMC Med Genet 10: 48.
16. Gadd S, Sredni ST, Huang CC, Perlman EJ. 2010. Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets. Lab Invest 90: 724-738.
17. Goodship J, Cross I, LiLing J, Wren C. 1998. A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 79: 348-351.
18. Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. 2007. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80: 805-810.
19. Isakoff MS, Sansam CG, Tamayo P, Subramanian A, Evans JA, Fillmore CM, Wang X, Biegel JA, Pomeroy SL, Mesirov JP, Roberts CW. 2005. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc Natl Acad Sci USA 102: 17745-17750.
20. Jackson EM, Shaikh TH, Gururangan S, Jones MC, Malkin D, Nikkel SM, Zuppan CW, Wainwright LM, Zhang F, Biegel JA. 2007. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Hum Genet 122: 117-127.
21. Kato H, Honma R, Sanda T, Fujiwara T, Ito E, Yanagisawa Y, Imai J, Okamoto T, Watanabe S. 2007. Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner. Biochem Biophys Res Commun 361: 580-585.
22. Katsumi Y, Kuwahara Y, Tamura S, Kikuchi K, Otabe O, Tsuchiya K, Iehara T, Kuroda H, Hosoi H, Sugimoto T. 2008. Trastuzumab activates allogeneic or autologous antibody-dependent cellular cytotoxicity against malignant rhabdoid tumor cells and interleukin-2 augments the cytotoxicity. Clin Cancer Res 14: 1192-1199.
23. Keller U, Huber J, Nilsson JA, Fallahi M, Hall MA, Peschel C, Cleveland JL. 2010. Myc suppression of Nfkb2 accelerates lymphomagenesis. BMC Cancer 10: 348.
24. Kleinschmidt-DeMasters BK, Alassiri AH, Birks DK, Newell KL, Moore W, Lillehei KO. 2010. Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6. Am J Surg Pathol 34: 341-354.
25. Kobrynski LJ, Sullivan KE. 2007. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370: 1443-1452.
26. Kook SD, An SK, Kim KR, Kim WJ, Lee E, Namkoong K. 2010. Psychotic features as the first manifestation of 22q11.2 deletion syndrome. Psychiatry Investig 7: 72-74.
27. Lafay-Cousin L, Payne E, Strother D, Chernos J, Chan M, Bernier FP. 2009. Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor. Am J Med Genet A 149A: 2855-2859.
28. Lee LA, Dang CV. 2006. Myc target transcriptomes. Curr Top Microbiol Immunol 302: 145-167.
29. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF, Scambler PJ, Bradley A, Baldini A. 2001. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410: 97-101.
30. Madigan CE, Armenian SH, Malogolowkin MH, Mascarenhas L. 2007. Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience. Cancer 110: 2061-2066.
31. Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM, Xavier RJ, Demay MB, Russell RG, Factor S, Tokooya K, Jore BS, Lopez M, Pandita RK, Lia M, Carrion D, Xu H, Schorle H, Kobler JB, Scambler P, Wynshaw-Boris A, Skoultchi AI, Morrow BE, Kucherlapati R. 2001. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104: 619-629.
32. Mikhail FM, Descartes M, Piotrowski A, Andersson R, Diaz de Stahl T, Komorowski J, Bruder CE, Dumanski JP, Carroll AJ. 2007. A previously unrecognized microdeletion syndrome on chromosome 22 band q11.2 encompassing the BCR gene. Am J Med Genet A 143A: 2178-2184.
33. Nagl NG, Jr., Zweitzig DR, Thimmapaya B, Beck GR, Jr., Moran E. 2006. The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest. Cancer Res 66: 1289-1293.
34. Nicolaides T, Tihan T, Horn B, Biegel J, Prados M, Banerjee A. 2010. High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol 98: 117-123.
35. Pfister SM, Korshunov A, Kool M, Hasselblatt M, Eberhart C, Taylor MD. 2010. Molecular diagnostics of CNS embryonal tumors. Acta Neuropathol 120: 553-566.
36. Rickert CH, Paulus W. 2004. Chromosomal imbalances detected by comparative genomic hybridisation in atypical teratoid/rhabdoid tumours. Childs Nerv Syst 20: 221-224.
37. Roberts CW, Biegel JA. 2009. The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther 8: 412-416.
38. Rorke LB, Packer R, Biegel J. 1995. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol 24: 21-28.
39. Rorke LB, Packer RJ, Biegel JA. 1996. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85: 56-65.
40. Savla J, Chen TT, Schneider NR, Timmons CF, Delattre O, Tomlinson GE. 2000. Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. J Natl Cancer Inst 92: 648-650.
41. Scambler PJ. 2000. The 22q11 deletion syndromes. Hum Mol Genet 9: 2421-2426.
42. Scambler PJ, Kelly D, Lindsay E, Williamson R, Goldberg R, Shprintzen R, Wilson DI, Goodship JA, Cross IE, Burn J. 1992. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 339: 1138-1139.
43. Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. 1999. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 65: 1342-1348.
44. Shaikh TH, Kurahashi H, Saitta SC, O'Hare AM, Hu P, Roe BA, Driscoll DA, McDonald-McGinn DM, Zackai EH, Budarf ML, Emanuel BS. 2000. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 9: 489-501.
45. Shaikh TH, Kurahashi H, Emanuel BS. 2001. Evolutionarily conserved low copy repeats (LCRs) in 22q11 mediate deletions, duplications, translocations, and genomic instability: an update and literature review. Genet Med 3: 6-13.
46. Shaikh TH, O'Connor RJ, Pierpont ME, McGrath J, Hacker AM, Nimmakayalu M, Geiger E, Emanuel BS, Saitta SC. 2007. Low copy repeats mediate distal chromosome 22q11.2 deletions: sequence analysis predicts breakpoint mechanisms. Genome Res 17: 482-491.
47. Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman MD, Argamaso RV, Young D. 1978. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 15: 56-62.
48. Stankiewicz P, Lupski JR. 2002. Genome architecture, rearrangements and genomic disorders. Trends Genet 18: 74-82.
49. Tang M, Wei X, Guo Y, Breslin P, Zhang S, Wei W, Xia Z, Diaz M, Akira S, Zhang J. 2008. TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. J Exp Med 205: 1611-1619.
50. Tomlinson GE, Breslow NE, Dome J, Guthrie KA, Norkool P, Li S, Thomas PR, Perlman E, Beckwith JB, D'Angio GJ, Green DM. 2005. Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol 23: 7641-7645.
51. Wieser R, Fritz B, Ullmann R, Muller I, Galhuber M, Storlazzi CT, Ramaswamy A, Christiansen H, Shimizu N, Rehder H. 2005. Novel rearrangement of chromosome band 22q11.2 causing 22q11 microdeletion syndrome-like phenotype and rhabdoid tumor of the kidney. Hum Mutat 26: 78-83.
52. Xu H, Cerrato F, Baldini A. 2005. Timed mutation and cell-fate mapping reveal reiterated roles of Tbx1 during embryogenesis, and a crucial function during segmentation of the pharyngeal system via regulation of endoderm expansion. Development 132: 4387-4395.
53. Yadav V, Yanez NC, Fenton SE, Denning MF. 2010. Loss of protein kinase C delta gene expression in human squamous cell carcinomas: a laser capture microdissection study. Am J Pathol 176: 1091-1096.
54. Zemble R, Luning Prak E, McDonald K, McDonald-McGinn D, Zackai E, Sullivan K. 2010. Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Immunol 136: 409-418.
55. Zhao L, Yaoita E, Nameta M, Zhang Y, Cuellar LM, Fujinaka H, Xu B, Yoshida Y, Hatakeyama K, Yamamoto T. 2008. Claudin-6 localized in tight junctions of rat podocytes. Am J Physiol Regul Integr Comp Physiol 294: R1856-R1862.